204 related articles for article (PubMed ID: 31281725)
1. miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.
Dai W; He J; Zheng L; Bi M; Hu F; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M
J Breast Cancer; 2019 Jun; 22(2):219-236. PubMed ID: 31281725
[TBL] [Abstract][Full Text] [Related]
2. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
3. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C
BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719
[TBL] [Abstract][Full Text] [Related]
4. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
5. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
7. Identification of chemoresistance-associated miRNAs in breast cancer.
Lou W; Liu J; Ding B; Xu L; Fan W
Cancer Manag Res; 2018; 10():4747-4757. PubMed ID: 30425571
[TBL] [Abstract][Full Text] [Related]
8. A two-microRNA signature predicts the progression of male thyroid cancer.
Liu B; Shi H; Qiu W; Wu X; Li L; Wu W
Open Life Sci; 2021; 16(1):981-991. PubMed ID: 34595349
[TBL] [Abstract][Full Text] [Related]
9. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
11. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
[TBL] [Abstract][Full Text] [Related]
12. Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Kim J
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33440868
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
14. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Liu H; Wang G
Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
[TBL] [Abstract][Full Text] [Related]
17. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
PeerJ; 2020; 8():e9100. PubMed ID: 32377460
[TBL] [Abstract][Full Text] [Related]
19. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
20. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
